Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7

Vaccine
F E HenkenR D M Steenbergen

Abstract

Persistent infection with high-risk human papillomaviruses (hrHPV) can result in the formation of anogenital cancers. As hrHPV proteins E6 and E7 are required for cancer initiation and maintenance, they are ideal targets for immunotherapeutic interventions. Previously, we have described the development of DNA vaccines for the induction of HPV16 E6 and E7 specific T cell immunity. These vaccines consist of 'gene-shuffled' (SH) versions of HPV16 E6 and E7 that were fused to Tetanus Toxin Fragment C domain 1 (TTFC) and were named TTFC-E6SH and TTFC-E7SH. Gene-shuffling was performed to avoid the risk of inducing malignant transformation at the vaccination site. Here, we describe the preclinical safety evaluation of these candidate vaccines by analysis of their transforming capacity in vitro using established murine fibroblasts (NIH 3T3 cells) and primary human foreskin keratinocytes (HFKs). We demonstrate that neither ectopic expression of TTFC-E6SH and TTFC-E7SH alone or in combination enabled NIH 3T3 cells to form colonies in soft agar. In contrast, expression of HPV16 E6WT and E7WT alone or in combination resulted in effective transformation. Similarly, retroviral transduction of HFKs from three independent donors with both TTF...Continue Reading

References

Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·G P DimriO Pereira-Smith
Nov 27, 1995·Annals of the New York Academy of Sciences·W W NicholsP J Troilo
Aug 1, 1996·Human Gene Therapy·T M Kinsella, G P Nolan
Mar 29, 2002·Journal of Clinical Pathology·F X BoschK V Shah
Jun 5, 2002·Nature Reviews. Cancer·Harald zur Hausen
Jan 6, 2004·Nature Reviews. Immunology·Ian H Frazer
Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M E ScheurerK Adler-Storthz
Dec 20, 2005·The Journal of Pathology·Peter J F SnijdersChris J L M Meijer
Oct 3, 2006·Human Vaccines·Johanna A C SchalkTjeerd G Kimman
Jul 14, 2007·Disease Markers·Joeli A BrinkmanW Martin Kast
Nov 15, 2008·Virology·Margaret E McLaughlin-Drubin, Karl Münger
Dec 17, 2008·Virology·Heather L HowieDenise A Galloway
Mar 21, 2009·Human Gene Therapy·Joost H van den BergJohn B A G Haanen
Dec 17, 2010·Nature Reviews. Cancer·C René LeemansRuud H Brakenhoff
Jan 6, 2011·International Journal of Cancer. Journal International Du Cancer·Koen OosterhuisJohn B Haanen
Jun 15, 2011·Molecular Cancer·Florianne E HenkenRenske D M Steenbergen

❮ Previous
Next ❯

Citations

May 28, 2013·Vaccine·I van der HeijdenB Nuijen
Mar 7, 2017·International Journal of Cancer. Journal International Du Cancer·Selina KhanJerome Custers
Feb 25, 2018·Expert Review of Anticancer Therapy·Marcelo Nazário CordeiroAntonio Carlos De Freitas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.